299 related articles for article (PubMed ID: 20102298)
1. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.
Annaert P; Ye ZW; Stieger B; Augustijns P
Xenobiotica; 2010 Mar; 40(3):163-76. PubMed ID: 20102298
[TBL] [Abstract][Full Text] [Related]
2. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
3. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
[TBL] [Abstract][Full Text] [Related]
4. Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes.
Ye ZW; Van Pelt J; Camus S; Snoeys J; Augustijns P; Annaert P
J Pharm Sci; 2010 Jun; 99(6):2886-98. PubMed ID: 20014428
[TBL] [Abstract][Full Text] [Related]
5. Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors.
Ye ZW; Augustijns P; Annaert P
Drug Metab Dispos; 2008 Jul; 36(7):1315-21. PubMed ID: 18420783
[TBL] [Abstract][Full Text] [Related]
6. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
[TBL] [Abstract][Full Text] [Related]
8. The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells.
Brenner S; Riha J; Giessrigl B; Thalhammer T; Grusch M; Krupitza G; Stieger B; Jäger W
Int J Oncol; 2015 Jan; 46(1):324-32. PubMed ID: 25351763
[TBL] [Abstract][Full Text] [Related]
9. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
[TBL] [Abstract][Full Text] [Related]
10. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.
Visentin M; Stieger B; Merz M; Kullak-Ublick GA
J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539
[TBL] [Abstract][Full Text] [Related]
11. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
Bednarczyk D; Boiselle C
Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
[TBL] [Abstract][Full Text] [Related]
12. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Roth M; Araya JJ; Timmermann BN; Hagenbuch B
J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.
Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ
Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T
Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300
[TBL] [Abstract][Full Text] [Related]
15. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
16. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
Treiber A; Schneiter R; Häusler S; Stieger B
Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.
Khurana V; Minocha M; Pal D; Mitra AK
Drug Metabol Drug Interact; 2014; 29(4):249-59. PubMed ID: 24807167
[TBL] [Abstract][Full Text] [Related]
18. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.
Chiou WJ; de Morais SM; Kikuchi R; Voorman RL; Li X; Bow DA
Xenobiotica; 2014 Mar; 44(3):276-82. PubMed ID: 23886114
[TBL] [Abstract][Full Text] [Related]
19. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake.
Shitara Y; Takeuchi K; Horie T
J Pharm Sci; 2013 Sep; 102(9):3427-35. PubMed ID: 23440887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
